GlassScriptPhysician profile
Colton D Briggs
NPI 1083292577
$1,037.50
in general payments reported to CMS, 2019-2025
16 companies · $597 in 2025
The $597 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.73 · 2023: $17.79 · 2024: $386 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.81 | 2024-2025 | |
| Novo Nordisk INC | $110.18 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $104.29 | 2024-2025 | Mounjaro, Jardiance |
| Exact Sciences Corporation | $101.11 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $99.78 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.59 | 2022-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Pfizer INC. | $78.24 | 2024 | |
| Merck Sharp & Dohme LLC | $60.81 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Dexcom, INC. | $43.64 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $39.37 | 2024-2025 | |
| Axsome Therapeutics, INC. | $26.95 | 2025 | Symbravo |
| Novartis Pharmaceuticals Corporation | $21.48 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $17.33 | 2025 | Farxiga |
| Xeris Pharmaceuticals, INC. | $16.60 | 2024 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $15.69 | 2025 | Inspire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $13.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colton Briggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.